Accéder au contenu
MilliporeSigma

Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.

Neurobiology of aging (2014-05-17)
Cecilia E Hanzel, Alexa Pichet-Binette, Luisa S B Pimentel, M Florencia Iulita, Simon Allard, Adriana Ducatenzeiler, Sonia Do Carmo, A Claudio Cuello
RÉSUMÉ

Chronic brain inflammation is associated with Alzheimer's disease (AD) and is classically attributed to amyloid plaque deposition. However, whether the amyloid pathology can trigger early inflammatory processes before plaque deposition remains a matter of debate. To address the possibility that a pre-plaque inflammatory process occurs, we investigated the status of neuronal, astrocytic, and microglial markers in pre- and post-amyloid plaque stages in a novel transgenic rat model of an AD-like amyloid pathology (McGill-R-Thy1-APP). In this model, we found a marked upregulation of several classical inflammatory markers such as COX-2, IL-1β, TNF-α, and fractalkine (CX3CL1) in the cerebral cortex and hippocampus. Interestingly, many of these markers were highly expressed in amyloid beta-burdened neurons. Activated astrocytes and microglia were associated with these Aβ-burdened neurons. These findings confirm the occurrence of a proinflammatory process preceding amyloid plaque deposition and suggest that Aβ-burdened neurons play a crucial role in initiating inflammation in AD.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Éthanol, ACS reagent, prima fine spirit, without additive, F15 o1
Sigma-Aldrich
Éthanol, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
USP
Éthanol, United States Pharmacopeia (USP) Reference Standard
Supelco
Éthanol, Pharmaceutical Secondary Standard; Certified Reference Material